FACTORS ASSOCIATED WITH LACK OF BIOLOGIC INITIATION IN PATIENTS WITH SEVERE UNCONTROLLED EOSINOPHILIC ASTHMA (SUEA)

被引：0
|
作者：
Corbridge, T.
Stach-Klysh, A.
Germain, G.
MacKnight, S.
Bou-Dreau, J.
Laliberte, F.
Deb, A.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
D012
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life
    Bagnasco, Diego
    Povero, Massimiliano
    Pradelli, Lorenzo
    Brussino, Luisa
    Rolla, Giovanni
    Caminati, Marco
    Menzella, Francesco
    Heffler, Enrico
    Canonica, Giorgio Walter
    Paggiaro, Pierluigi
    Senna, Gianenrico
    Milanese, Manlio
    Lombardi, Carlo
    Bucca, Caterina
    Manfredi, Andrea
    Canevari, Rikki Frank
    Passalacqua, Giovanni
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (02):
  • [42] Severe uncontrolled allergic eosinophilic asthma - looking for the best therapeutic option
    Kuprys-Lipinska, Izabela
    Kuna, Piotr
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2020, 7 (04) : 180 - 189
  • [43] FACTORS ASSOCIATED WITH BIOLOGIC OR MAINTENANCE SYSTEMIC CORTICOSTEROID TREATMENT AMONG UNITED STATES SEVERE ASTHMA PATIENTS
    Chipps, B.
    Ambrose, C.
    Trevor, J.
    Belton, L.
    Gandhi, H.
    Lugogo, N.
    Soong, W.
    Carr, W.
    Moore, W.
    Trudo, F.
    Panettieri, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S33 - S33
  • [44] Quantifying patients referred to a severe uncontrolled asthma unit with a final diagnosis of true severe uncontrolled asthma
    Gonzalez, De Olano D.
    Velasco-Alvarez, D.
    Chiluiza-Reyes, D. P.
    Rodriguez-Calle, C.
    Lopez-Neyra, A.
    Almonacid-Sanchez, C.
    ALLERGY, 2020, 75 : 407 - 407
  • [45] Prognostic factors in severe eosinophilic asthma in children
    Martinez Rivera, Carlos
    Padro Casas, Clara
    Basagana Torrento, Maria
    Rivera Ortun, Marisa
    Pollan Guisasola, Carlos
    Navarro Ferrando, Jose Tomas
    Martinez Caceres, Eva
    Teniente Serra, Aina
    Francoso Vicente, Alicia
    Martinez Colls, Maria Del Mar
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [46] Healthcare Resource Use Associated With Exacerbations In Patients With Severe Eosinophilic Asthma
    Forshag, M.
    Dalal, A. A.
    Ortega, H.
    Yancey, S.
    Gunsoy, N. B.
    Canonica, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [47] Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain
    Joulain, Florence
    Borsos, Kinga
    Cheng, Wei-Han
    Engroba-Teijeiro, Clara
    Wang, Zhixiao
    JOURNAL OF ASTHMA, 2025, 62 (02) : 362 - 364
  • [48] Cost-effectiveness of benralizumab versus mepolizumab and dupilumab in patients with severe uncontrolled eosinophilic asthma in Spain
    Mareque, M.
    Climente, M.
    Martinez-Moragon, E.
    Padilla, A.
    Oyaguez, I
    Touron, C.
    Torres, C.
    Martinez, A.
    JOURNAL OF ASTHMA, 2023, 60 (06) : 1210 - 1220
  • [49] The COVID-19 impact on severe uncontrolled asthma costs and biologic use
    Khan, Najm S.
    Rubin, Elizabeth
    McKenna, Bernard
    Palowitch, Bernard L.
    Sonnenberg, Frank
    Argon, Judith
    Panettieri, Reynold A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2023, 44 (05) : 340 - 344
  • [50] Benefits of Mepolizumab in patients with severe uncontrolled asthma
    Soto Hurtado, E.
    Rodriguez Gallego, Y.
    Vicente Gil, P.
    PNEUMOLOGIE, 2024, 78 : S61 - S61
12345